Cite
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations
MLA
Yonehiro Kanemura, et al. “TERT Promoter Mutation Confers Favorable Prognosis Regardless of 1p/19q Status in Adult Diffuse Gliomas with IDH1/2 Mutations.” Acta Neuropathologica Communications, vol. 8, no. 1, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f8d98a03627094d2c8a28e4361ecb344&authtype=sso&custid=ns315887.
APA
Yonehiro Kanemura, Masayuki Kanamori, Fumi Higuchi, Yoshitaka Narita, Ken ichiro Matsuda, Yukitomo Ishi, Shunsaku Takayanagi, Kuniaki Saito, Takashi Komori, Ryunosuke Machida, Yohei Miyake, Takashi Sasayama, Ryo Nishikawa, Yasuhiko Hattori, Ryusuke Hatae, Koichi Ichimura, Teiji Tominaga, Masahiro Mizoguchi, Ryohei Otani, … Kazuhiro Tanaka. (2020). TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Acta Neuropathologica Communications, 8(1).
Chicago
Yonehiro Kanemura, Masayuki Kanamori, Fumi Higuchi, Yoshitaka Narita, Ken ichiro Matsuda, Yukitomo Ishi, Shunsaku Takayanagi, et al. 2020. “TERT Promoter Mutation Confers Favorable Prognosis Regardless of 1p/19q Status in Adult Diffuse Gliomas with IDH1/2 Mutations.” Acta Neuropathologica Communications 8 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f8d98a03627094d2c8a28e4361ecb344&authtype=sso&custid=ns315887.